PerSimiO (פרסימיו)
Beersheba, Israel
PerSimiO offers a bone-strength prediction technology validated by ex-vivo experiments on a large cohort of bones. PerSimiO develops Simfini, a SaaS simulation tool that can provide patient-specific bone analysis, predict the risk of fracture, and select an orthopedic implant for optimal fit. The company has developed four products, Simfini-TUMOR, Simfini-OSTEO, Simfini-IMPLANT, and Simfini-DIABETES, which will identify patients at high risk of contralateral hip fracture and enable better planning, treatment, and oversight to minimize the risk. The company's products target the diagnosis and treatment of a variety of diseases including osteoporosis, metastatic tumors, and injuries that weaken the bone. The products are designed to optimize treatment and improve outcomes at a reduced cost. PerSimiO has conducted clinical trials at three medical centers in Israel.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2015
- Website
- www.persimio.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of PerSimiO (פרסימיו)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now